Picture of Xvivo Perfusion AB logo

XVIVO — Xvivo Perfusion AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapFalling Star

Brief: Xvivo Perfusion Q1 EBITDA decreases to SEK 5.0 mln

April 25 (Reuters) - XVIVO PERFUSION AB  XVIVO.ST  
    * Q1 OPERATING INCOME BEFORE DEPRECIATION AND AMORTIZATION 
(EBITDA), EXCLUDING ITEMS AFFECTING COMPARABILITY, AMOUNTED TO 
SEK 5.0 (7.3) MILLION 
    * BOARD OF DIRECTORS HAS RESOLVED UPON A NEW ISSUE OF UP TO 
181 MSEK DIRECTED TO INSTITUTIONAL INVESTORS 
    * NET SALES OF NON-DURABLE GOODS IN QUARTER 1 AMOUNTED TO 
SEK 33.6 (29.1) MILLION, CORRESPONDING TO AN INCREASE OF 16 
PERCENT IN SEK 
    * Q1  NET SALES AMOUNTED TO SEK 37.5 (33.5) MILLION, 
CORRESPONDING TO AN INCREASE OF 12 PERCENT 
 
Source text for Eikon:  ID:nWkr30BnPD  
Further company coverage:  XVIVO.ST  
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com;))

Recent news on Xvivo Perfusion AB

See all news